Morepen Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	273.81	169.45	216.66	158.03	413.87
Short-Term Investments	-	778.07	-	-	-	-
Cash & Short-Term Investments	808.74	1,052	169.45	216.66	158.03	413.87
Cash Growth	-56.62%	520.76%	-21.79%	37.10%	-61.82%	203.44%
Accounts Receivable	-	3,248	3,249	2,632	2,506	1,820
Other Receivables	-	23.23	63.51	26.03	31.57	88.3
Receivables	-	3,276	3,315	2,661	2,541	1,911
Inventory	-	3,000	2,486	2,289	2,759	1,753
Prepaid Expenses	-	691.33	100.71	45.3	21.21	11.75
Other Current Assets	-	3,575	2,819	2,350	1,864	1,178
Total Current Assets	-	11,594	8,890	7,562	7,343	5,268
Property, Plant & Equipment	-	3,703	2,377	1,840	1,608	1,312
Long-Term Investments	-	71.74	13.01	-	-	10.85
Goodwill	-	744.74	744.74	744.74	744.74	744.74
Other Intangible Assets	-	720.43	196.68	254.99	306.77	207.65
Other Long-Term Assets	-	945.59	710.26	702.95	697.5	1,037
Total Assets	-	17,781	12,932	11,105	10,701	8,581
Accounts Payable	-	3,633	2,950	2,269	2,581	2,088
Accrued Expenses	-	278.81	291.46	250.44	207.37	202.25
Short-Term Debt	-	460.36	234.91	231.8	161.32	153.24
Current Portion of Long-Term Debt	-	75.99	21.44	10.51	1,158	1,205
Current Portion of Leases	-	122.18	-	-	-	-
Current Income Taxes Payable	-	101.27	166	79.6	101.51	39.67
Other Current Liabilities	-	334.9	356.36	370.5	355.53	348.9
Total Current Liabilities	-	5,007	4,020	3,212	4,565	4,038
Long-Term Debt	-	257.58	33.64	9.34	13.21	8.28
Long-Term Leases	-	134.84	-	-	-	-
Pension & Post-Retirement Benefits	-	298.97	265.93	225.66	208.69	188.29
Long-Term Deferred Tax Liabilities	-	69.77	22.5	26.86	24.83	-
Other Long-Term Liabilities	-	143.73	117.28	106.99	108.22	103.98
Total Liabilities	-	5,911	4,460	3,580	4,920	4,339
Common Stock	-	1,096	1,022	1,022	955.59	899.59
Additional Paid-In Capital	-	5,532	3,698	3,698	2,318	1,674
Retained Earnings	-	4,042	2,862	1,900	1,513	546.54
Comprehensive Income & Other	-	892.92	890.39	908.8	998.61	1,127
Total Common Equity	11,962	11,562	8,472	7,529	5,786	4,247
Minority Interest	-	307.27	-	-4.6	-4.61	-4.59
Shareholders' Equity	11,969	11,870	8,472	7,524	5,781	4,243
Total Liabilities & Equity	-	17,781	12,932	11,105	10,701	8,581
Total Debt	1,585	1,051	289.99	251.64	1,332	1,367
Net Cash (Debt)	-775.88	0.93	-120.54	-34.98	-1,174	-953.11
Net Cash Per Share	-1.41	0.00	-0.24	-0.07	-2.26	-2.11
Filing Date Shares Outstanding	550.19	547.95	511.17	511.17	477.83	449.83
Total Common Shares Outstanding	550.19	547.95	511.17	511.17	477.83	449.83
Working Capital	-	6,587	4,870	4,350	2,778	1,230
Book Value Per Share	21.77	21.10	16.57	14.73	12.11	9.44
Tangible Book Value	10,855	10,097	7,531	6,529	4,734	3,295
Tangible Book Value Per Share	19.75	18.43	14.73	12.77	9.91	7.33
Land	-	232.69	14.33	14.33	14.33	15.82
Buildings	-	1,123	996.08	908.72	814.08	792.56
Machinery	-	4,568	3,736	4,036	3,804	4,194
Construction In Progress	-	283.41	244.52	170.14	141.46	19.56

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.